31st Mar 2016 16:55
LONDON (Alliance News) - Hikma Pharmaceuticals PLC said Darhold Ltd, in which its chairman and chief executive holds a stake in, purchased 30,000 shares in the company on Thursday at a price of 1,972.0 pence each.
Those shares represent 0.012% of Hikma's issued share capital, and following the transaction, Chairman and Chief Executive Said Darwazah is interested in a total of 13.1 million Hikma shares, representing a 5.48% stake in the company.
Breaking that stake down, Darwazah directly holds 657,000 shares in Hikma, representing a 0.28% stake, and is then interested in a further 12.5 million shares through Darhold, which is equal to a 5.2% stake.
Hikma shares closed up 0.5% to 1,976.42 pence per share on Thursday.
By Joshua Warner; [email protected]; @JoshAlliance
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
Hikma Pharmaceuticals